Short answer
ResMed (RMD) filed an 8-K current report with the SEC on July 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Definitive agreement to sell MatrixCare business to Frazier Healthcare Partners.
ResMed 8-K event analysis
AI summary of each reported item and its exhibits
Item EX-99.1 · Exhibit EX-99.1
- Definitive agreement to sell MatrixCare business to Frazier Healthcare Partners
- Divestiture covers MatrixCare, Healthcare First, Citus, and home health and hospice software
- MatrixCare serves more than 15,000 providers across post-acute and long-term care markets
- Excludes ResMed’s Brightree and MEDIFOX DAN software businesses
- Expected closing in ResMed’s fiscal Q1 2027, subject to regulatory approvals and customary conditions
Other items in this filing:
- Item 2.02: Results of Operations and Financial Condition
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ResMed 8-K filings
Get the next RMD 8-K as it lands
Follow RMD for push alerts, or ask the research agent what this filing means.